1. Home
  2. CDZIP vs CGEN Comparison

CDZIP vs CGEN Comparison

Compare CDZIP & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDZIP
  • CGEN
  • Stock Information
  • Founded
  • CDZIP N/A
  • CGEN 1993
  • Country
  • CDZIP United States
  • CGEN Israel
  • Employees
  • CDZIP 25
  • CGEN N/A
  • Industry
  • CDZIP Water Supply
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CDZIP Utilities
  • CGEN Health Care
  • Exchange
  • CDZIP Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • CDZIP N/A
  • CGEN 125.3M
  • IPO Year
  • CDZIP N/A
  • CGEN 2000
  • Fundamental
  • Price
  • CDZIP $19.46
  • CGEN $1.36
  • Analyst Decision
  • CDZIP
  • CGEN
  • Analyst Count
  • CDZIP 0
  • CGEN 0
  • Target Price
  • CDZIP N/A
  • CGEN N/A
  • AVG Volume (30 Days)
  • CDZIP N/A
  • CGEN 243.4K
  • Earning Date
  • CDZIP N/A
  • CGEN 11-11-2025
  • Dividend Yield
  • CDZIP N/A
  • CGEN N/A
  • EPS Growth
  • CDZIP N/A
  • CGEN N/A
  • EPS
  • CDZIP N/A
  • CGEN N/A
  • Revenue
  • CDZIP N/A
  • CGEN $22,144,000.00
  • Revenue This Year
  • CDZIP N/A
  • CGEN N/A
  • Revenue Next Year
  • CDZIP N/A
  • CGEN $208.08
  • P/E Ratio
  • CDZIP N/A
  • CGEN N/A
  • Revenue Growth
  • CDZIP N/A
  • CGEN N/A
  • 52 Week Low
  • CDZIP N/A
  • CGEN $1.13
  • 52 Week High
  • CDZIP N/A
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • CDZIP 69.64
  • CGEN 39.56
  • Support Level
  • CDZIP $19.14
  • CGEN $1.32
  • Resistance Level
  • CDZIP $19.14
  • CGEN $1.47
  • Average True Range (ATR)
  • CDZIP 0.37
  • CGEN 0.06
  • MACD
  • CDZIP -0.00
  • CGEN -0.00
  • Stochastic Oscillator
  • CDZIP 61.96
  • CGEN 22.22

About CDZIP Cadiz Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: